All News

Urology Times has received two awards for cover design in recent national journalism competitions.

Mylan Pharmaceuticals Inc., Sun Pharmaceutical Industries, and Sandoz Inc. have received FDA approval for their generic formulations of bicalutamide tablets, 50 mg.

Micheal Chehval, MD, has been appointed chief of urology at Saint Louis University School of Medicine.

Through a new contractual relationship between Cook Medical and Premier Purchasing Partners, LP, more than 2,100 U.S. hospitals and 58,000 additional health care providers will have access to special pricing and terms of Cook?s Biodesign Advanced Tissue Repair products, designed for four types of soft tissue repair: continence restoration, fistula repair, vaginal erosion repair, and pelvic floor reconstruction.

American Medical Systems, Inc. has received FDA approval for the AMS 700 with Inhibizone as the only inflatable penile prosthesis with clinical evidence showing a significant reduction in the rate of revision surgery due to infection.

Treatment with sunitinib malate (Sutent) appears to prolong progression-free and overall survival, and is safe and well tolerated in advanced kidney cancer patients with a poor prognosis, including the elderly and those whose cancer has spread to the brain, according to a study to be published in The Lancet Oncology.

Treatments for prostate cancer are among 100 health topics that should receive priority attention and funding from a new national research effort to identify which health care services are most effective.

John Wertman has been appointed government relations and advocacy manager, states and sections, for AUA?s expanded government relations program.

Prostate cancer patients who receive brachytherapy and remain free of disease for 5 years are unlikely to have a recurrence at 10 years, according a new study by researchers from Mount Sinai Medical Center, New York.

Caldera Medical, Inc. (Agoura Hills, CA) has received FDA clearance for the Ascend Pelvic Floor Repair System with Apical Support for female pelvic organ prolapse treatment.

The FDA is requiring manufacturers of two prescription topical testosterone gel products, AndroGel 1% and Testim 1%, to include a boxed warning on the products? labels after receiving reports of adverse effects in children who were inadvertently exposed to testosterone through secondary exposure.

The FDA is requiring manufacturers of two prescription topical testosterone gel products, AndroGel 1% and Testim 1%, to include a boxed warning on the products? labels after receiving reports of adverse effects in children who were inadvertently exposed to testosterone through secondary exposure.

Increases in urologists? overall compensation did not keep up with inflation in 2008, according to a survey by the Medical Group Management Association. The same finding held true for several other physician specialties and primary care providers.

360 Network

Severe vaginal vault prolapse affects more than 3 million women in the United States, and 11% of women will require prolapse or incontinence surgeries in their lifetime. This article discusses the range of evolving surgical options for repairing rectocele, cystocele, and enterocele, with an emphasis on techniques using synthetic mesh.

Further analysis of the REDUCE (Reduction by Dutasteride of Prostate Cancer Events) trial will help answer important questions and direct therapy.

RPLND alone provides up to 90% cure in patients with low-volume, low-risk testis cancer and eliminates the risk of teratoma and viable tumor in the retroperitoneum in those with high-risk disease.

New Products

Results of a milestone study on the use of an experimental form of immunotherapy may usher in a new era in the management of androgen-independent prostate cancer.

Ureteroscopy is more effective than extracorporeal shock wave lithotripsy for the treatment of proximal ureteral stones.

With the current physician shortage, if you plan to bring another physician into the practice, you'd better do it right.

Dutasteride (Avodart) reduces the risk of biopsy-detectable prostate cancer by about one-fourth in men at high risk for the disease without increasing the risk of high-grade cancers. In addition, the 5-alpha-reductase inhibitor significantly enhances the utility of PSA as a diagnostic test for prostate cancer.

Findings from a multicenter, randomized, double-blind, placebo-controlled study are consistent with previously reported data showing that tadalafil (Cialis) improves lower urinary tract symptoms associated with BPH.

The traditional prescribing process can be inefficient. We help you understand the definition of e-prescribing, the case for e-prescribing, and how to get started.

Prostate cancer research deserves the same level of government commitment that other forms of cancer receive, even those that affect young children.

It is important to be aware of the general arrangements (often referred to as "platforms") available for investment management and the alternative methods of compensation for those who are involved in retirement plan accounts.

Sealing the percutaneous tract is not necessary if patients have been rigorously selected for tubeless percutaneous nephrolithotomy.